前のページに戻る この文献は全文を取り寄せることができます
JDreamⅢ複写サービスから文献全文の複写(冊子体のコピー)をお申込みできます。
ご利用には、G-Searchデータベースサービスまたは、JDreamⅢのIDが必要です。
既に、G-Searchデータベースサービスまたは、JDreamⅢのIDをお持ちの方
JDreamⅢ複写サービスのご利用が初めての方
取り寄せる文献のタイトルと詳細
文献
J-GLOBAL ID:202202210678098576   整理番号:22A0576118

虚弱表現型による心不全患者の遠隔医療の有効性:iCOR無作為化対照試験からの洞察【JST・京大機械翻訳】

Effectiveness of telemedicine in patients with heart failure according to frailty phenotypes: Insights from the iCOR randomised controlled trial
著者 (50件):
Yun Sergi
(Community Heart Failure Program, Departments of Cardiology and Internal Medicine, Bellvitge University Hospital, L’Hospitalet de Llobregat, Barcelona, Spain)
Yun Sergi
(Bio-Heart Cardiovascular Diseases Research Group, Bellvitge Biomedical Research Institute (IDIBELL), L’Hospitalet de Llobregat, Barcelona, Spain)
Yun Sergi
(Department of Internal Medicine, Bellvitge University Hospital, L’Hospitalet de Llobregat, Barcelona, Spain)
Enjuanes Cristina
(Community Heart Failure Program, Departments of Cardiology and Internal Medicine, Bellvitge University Hospital, L’Hospitalet de Llobregat, Barcelona, Spain)
Enjuanes Cristina
(Bio-Heart Cardiovascular Diseases Research Group, Bellvitge Biomedical Research Institute (IDIBELL), L’Hospitalet de Llobregat, Barcelona, Spain)
Enjuanes Cristina
(Department of Cardiology, Bellvitge University Hospital, L’Hospitalet de Llobregat, Barcelona, Spain)
Calero-Molina Esther
(Community Heart Failure Program, Departments of Cardiology and Internal Medicine, Bellvitge University Hospital, L’Hospitalet de Llobregat, Barcelona, Spain)
Calero-Molina Esther
(Bio-Heart Cardiovascular Diseases Research Group, Bellvitge Biomedical Research Institute (IDIBELL), L’Hospitalet de Llobregat, Barcelona, Spain)
Calero-Molina Esther
(Department of Cardiology, Bellvitge University Hospital, L’Hospitalet de Llobregat, Barcelona, Spain)
Hidalgo Encarnacion
(Community Heart Failure Program, Departments of Cardiology and Internal Medicine, Bellvitge University Hospital, L’Hospitalet de Llobregat, Barcelona, Spain)
Hidalgo Encarnacion
(Bio-Heart Cardiovascular Diseases Research Group, Bellvitge Biomedical Research Institute (IDIBELL), L’Hospitalet de Llobregat, Barcelona, Spain)
Hidalgo Encarnacion
(Department of Cardiology, Bellvitge University Hospital, L’Hospitalet de Llobregat, Barcelona, Spain)
Jose Nuria
(Community Heart Failure Program, Departments of Cardiology and Internal Medicine, Bellvitge University Hospital, L’Hospitalet de Llobregat, Barcelona, Spain)
Jose Nuria
(Bio-Heart Cardiovascular Diseases Research Group, Bellvitge Biomedical Research Institute (IDIBELL), L’Hospitalet de Llobregat, Barcelona, Spain)
Jose Nuria
(Department of Cardiology, Bellvitge University Hospital, L’Hospitalet de Llobregat, Barcelona, Spain)
Calvo Elena
(Bio-Heart Cardiovascular Diseases Research Group, Bellvitge Biomedical Research Institute (IDIBELL), L’Hospitalet de Llobregat, Barcelona, Spain)
Calvo Elena
(Department of Cardiology, Bellvitge University Hospital, L’Hospitalet de Llobregat, Barcelona, Spain)
Calvo Elena
(Faculty of medicine and Health Sciences, School of Nursing, University of Barcelona (UB), Barcelona, Spain)
Verdu-Rotellar Jose Maria
(Heart Diseases Biomedical Research Group, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain)
Verdu-Rotellar Jose Maria
(School of Medicine, Universitat Autonoma de Barcelona, Barcelona, Spain)
Verdu-Rotellar Jose Maria
(Jordi Gol Primary Care Research Institute, Catalan Institute of Heath, Barcelona, Spain)
Garcimartin Paloma
(Heart Diseases Biomedical Research Group, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain)
Garcimartin Paloma
(Outpatient Clinics, Hospital del Mar, Parc de Salut Mar, Barcelona, Spain)
Garcimartin Paloma
(Escuela Superior de Enfermeria del Mar, Parc de Salut Mar, Barcelona, Spain)
Chivite David
(Department of Internal Medicine, Bellvitge University Hospital, L’Hospitalet de Llobregat, Barcelona, Spain)
Chivite David
(Bellvitge Biomedical Research Institute (IDIBELL), L’Hospitalet de Llobregat, Barcelona, Spain)
Formiga Francesc
(Department of Internal Medicine, Bellvitge University Hospital, L’Hospitalet de Llobregat, Barcelona, Spain)
Formiga Francesc
(Bellvitge Biomedical Research Institute (IDIBELL), L’Hospitalet de Llobregat, Barcelona, Spain)
Jimenez-Marrero Santiago
(Community Heart Failure Program, Departments of Cardiology and Internal Medicine, Bellvitge University Hospital, L’Hospitalet de Llobregat, Barcelona, Spain)
Jimenez-Marrero Santiago
(Bio-Heart Cardiovascular Diseases Research Group, Bellvitge Biomedical Research Institute (IDIBELL), L’Hospitalet de Llobregat, Barcelona, Spain)
Jimenez-Marrero Santiago
(Department of Cardiology, Bellvitge University Hospital, L’Hospitalet de Llobregat, Barcelona, Spain)
Jimenez-Marrero Santiago
(Department of Cardiology, Cardio-Oncology Unit, Bellvitge University Hospital and Catalan Institute of Oncology, L’Hospitalet del Llobregat, Barcelona, Spain)
Garay Alberto
(Community Heart Failure Program, Departments of Cardiology and Internal Medicine, Bellvitge University Hospital, L’Hospitalet de Llobregat, Barcelona, Spain)
Garay Alberto
(Bio-Heart Cardiovascular Diseases Research Group, Bellvitge Biomedical Research Institute (IDIBELL), L’Hospitalet de Llobregat, Barcelona, Spain)
Garay Alberto
(Department of Cardiology, Bellvitge University Hospital, L’Hospitalet de Llobregat, Barcelona, Spain)
Garay Alberto
(Department of Cardiology, Cardio-Oncology Unit, Bellvitge University Hospital and Catalan Institute of Oncology, L’Hospitalet del Llobregat, Barcelona, Spain)
Alcoberro Lidia
(Community Heart Failure Program, Departments of Cardiology and Internal Medicine, Bellvitge University Hospital, L’Hospitalet de Llobregat, Barcelona, Spain)
Alcoberro Lidia
(Bio-Heart Cardiovascular Diseases Research Group, Bellvitge Biomedical Research Institute (IDIBELL), L’Hospitalet de Llobregat, Barcelona, Spain)
Alcoberro Lidia
(Department of Cardiology, Bellvitge University Hospital, L’Hospitalet de Llobregat, Barcelona, Spain)
Moliner Pedro
(Community Heart Failure Program, Departments of Cardiology and Internal Medicine, Bellvitge University Hospital, L’Hospitalet de Llobregat, Barcelona, Spain)
Moliner Pedro
(Bio-Heart Cardiovascular Diseases Research Group, Bellvitge Biomedical Research Institute (IDIBELL), L’Hospitalet de Llobregat, Barcelona, Spain)
Moliner Pedro
(Department of Cardiology, Bellvitge University Hospital, L’Hospitalet de Llobregat, Barcelona, Spain)
Moliner Pedro
(Department of Cardiology, Cardio-Oncology Unit, Bellvitge University Hospital and Catalan Institute of Oncology, L’Hospitalet del Llobregat, Barcelona, Spain)
Corbella Xavier
(Department of Internal Medicine, Bellvitge University Hospital, L’Hospitalet de Llobregat, Barcelona, Spain)
Corbella Xavier
(Bellvitge Biomedical Research Institute (IDIBELL), L’Hospitalet de Llobregat, Barcelona, Spain)
Corbella Xavier
(Hestia Chair in Integrated Health and Social Care, School of Medicine, Universitat Internacional de Catalunya, Barcelona, Spain)
Comin-Colet Josep
(Community Heart Failure Program, Departments of Cardiology and Internal Medicine, Bellvitge University Hospital, L’Hospitalet de Llobregat, Barcelona, Spain)
Comin-Colet Josep
(Bio-Heart Cardiovascular Diseases Research Group, Bellvitge Biomedical Research Institute (IDIBELL), L’Hospitalet de Llobregat, Barcelona, Spain)
Comin-Colet Josep
(Department of Cardiology, Bellvitge University Hospital, L’Hospitalet de Llobregat, Barcelona, Spain)
Comin-Colet Josep
(Department of Clinical Sciences, School of Medicine, University of Barcelona (UB), Barcelona, Spain)

資料名:
European Journal of Internal Medicine  (European Journal of Internal Medicine)

巻: 96  ページ: 49-59  発行年: 2022年 
JST資料番号: W3247A  ISSN: 0953-6205  資料種別: 逐次刊行物 (A)
記事区分: 原著論文  発行国: オランダ (NLD)  言語: 英語 (EN)
JDreamⅢ複写サービスとは
JDreamⅢ複写サービスは、学術文献の全文を複写(コピー)して取り寄せできる有料サービスです。インターネットに公開されていない文献や、図書館に収録されていない文献の全文を、オンラインで取り寄せることができます。J-GLOBALの整理番号にも対応しているので、申し込みも簡単にできます。全文の複写(コピー)は郵送またはFAXでお送りします

※ご利用には、G-Searchデータベースサービスまたは、JDreamⅢのIDが必要です
※初めてご利用される方は、JDreamⅢ複写サービスのご案内をご覧ください。